-
公开(公告)号:KR1020040059139A
公开(公告)日:2004-07-05
申请号:KR1020020085716
申请日:2002-12-28
Applicant: (주)아모레퍼시픽
IPC: A61K31/704
CPC classification number: A61K31/70
Abstract: PURPOSE: Provided is a controlling agent of Bcl-2 expression which characteristically contains ginsenoside F1(20-O-beta-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the formula(1), as an active ingredient. It prevents apoptosis caused by radiating low doses of ultraviolet rays, while promoting apoptosis when radiating high doses of ultraviolet rays, therefore it removes the risk of cancers. CONSTITUTION: A controlling agent of the expression of Bcl-2 is characterized by containing ginsenoside F1(20-O-beta-D-glucopyranosyl-20(S)-protopanaxatriol), which is represented by the formula(1), as an active ingredient. It inhibits the decrease of Bcl-2 expression caused by radiating ultraviolet rays. Therefore, it prevents apoptosis by the radiation of low doses of ultraviolet rays, but promotes apoptosis by the radiation of high doses of ultraviolet rays.
Abstract translation: 目的:提供一种Bcl-2表达的控制剂,其特征在于含有式(1)所示的人参皂甙F1(20-O-β-D-吡喃葡萄糖基-20(S) - 原人参三醇)作为活性成分。 防止辐射低剂量紫外线引起的细胞凋亡,同时在辐射高剂量的紫外线时促进细胞凋亡,从而消除癌症的风险。 构成:Bcl-2表达的控制剂的特征在于将由式(1)表示的人参皂甙F1(20-O-β-D-吡喃葡萄糖基-20(S) - 原人参三醇)作为活性物质 成分。 它抑制由辐射紫外线引起的Bcl-2表达的降低。 因此,通过低剂量的紫外线辐射可防止细胞凋亡,但通过高剂量紫外线的辐射促进细胞凋亡。
-
公开(公告)号:KR102213922B1
公开(公告)日:2021-02-08
申请号:KR1020170083517
申请日:2017-06-30
Applicant: (주)아모레퍼시픽
Abstract: 섬유아세포및 콜라겐을혼합하여진피모사층을형성하는단계, 상기진피모사층위에각질형성세포를적용한후 배양하는단계, 그리고상기각질형성세포가적용된진피모사층을파이루베이트성분이제거된표피배양배지에서배양하는단계를포함하는인공피부제조방법을제공한다.
-
-
公开(公告)号:KR102087188B1
公开(公告)日:2020-03-11
申请号:KR1020170121801
申请日:2017-09-21
Applicant: (주)아모레퍼시픽
IPC: A61K8/9789 , A61K36/73 , A23L33/105 , A61Q19/00
-
-
-
-
-
-
公开(公告)号:KR101800243B1
公开(公告)日:2017-12-20
申请号:KR1020110060484
申请日:2011-06-22
Applicant: (주)아모레퍼시픽
IPC: C12N15/113 , A61Q7/00 , A61Q19/00 , C12Q1/68
Abstract: 본발명은서열번호 1의 miRNA 또는서열번호 2인안티센스핵산분자를유효성분으로포함하는백모방지및 흑모생성또는피부미백효과조성물을제공한다. 또한, 본발명은시험물질에대한색소형성유전자의발현조절물질을스크리닝하는방법으로서, 서열번호 1의 miRNA 또는서열번호 2인안티센스핵산분자를세포에트랜스펙션시키는단계; 상기세포에시험물질을처리하는단계; 및상기시험물질이색소형성유전자의발현을촉진하는지또는억제하는지여부를확인하는단계;를포함하는것을특징으로하는색소형성유전자의발현조절물질스크리닝방법을제공한다.
-
-
-
-
-
-
-
-
-